{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,6,3]],"date-time":"2023-06-03T06:10:16Z","timestamp":1685772616223},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,9,7]],"date-time":"2010-09-07T00:00:00Z","timestamp":1283817600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1007\/s00296-010-1606-z","type":"journal-article","created":{"date-parts":[[2010,9,6]],"date-time":"2010-09-06T12:56:05Z","timestamp":1283777765000},"page":"199-206","source":"Crossref","is-referenced-by-count":13,"title":["The balance between soluble receptors regulating IL-6 trans-signaling is predictive for the RANKL\/osteoprotegerin ratio in postmenopausal women with rheumatoid arthritis"],"prefix":"10.1007","volume":"32","author":[{"given":"Peter","family":"Oelzner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sybille","family":"Franke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriele","family":"Lehmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thorsten","family":"Eidner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gert","family":"Hein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gunter","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,9,7]]},"reference":[{"key":"1606_CR1","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/46303","volume":"402","author":"YY Kong","year":"1999","unstructured":"Kong YY, Feige U, Sarosi I, Bolon B, Tafuri A, Morony S, Capparelli C, Li J, Elliott R, McCabe S, Wong T, Campagnuolo G, Moran E, Bogoch ER, Van G, Nguyen LT, Ohashi PS, Lacey DL, Fish E, Boyle WJ, Penninger JM (1999) Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature 402:304\u2013309","journal-title":"Nature"},{"key":"1606_CR2","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/1529-0131(200002)43:2<250::AID-ANR3>3.0.CO;2-P","volume":"43","author":"EM Gravallese","year":"2000","unstructured":"Gravallese EM, Manning C, Tsay A, Naito A, Pan C, Amento E, Goldring SR (2000) Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor. Arthritis Rheum 43:250\u2013258","journal-title":"Arthritis Rheum"},{"key":"1606_CR3","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/1529-0131(200002)43:2<259::AID-ANR4>3.0.CO;2-W","volume":"43","author":"H Takayanagi","year":"2000","unstructured":"Takayanagi H, Iizuka H, Juji T, Nakagawa T, Yamamoto A, Miyazaki T, Koshihara Y, Oda H, Nakamura K, Tanaka S (2000) Involvement of receptor activator of nuclear factor kappaB ligand\/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis. Arthritis Rheum 43:259\u2013269","journal-title":"Arthritis Rheum"},{"key":"1606_CR4","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1002\/art.11150","volume":"48","author":"G Schett","year":"2003","unstructured":"Schett G, Redlich K, Hayer S, Zwerina J, Bolon B, Dunstan C, Gortz B, Schulz A, Bergmeister H, Kollias G, Steiner G, Smolen JS (2003) Osteoprotegerin protects against generalized bone loss in tumor necrosis factor-transgenic mice. Arthritis Rheum 48:2042\u20132051","journal-title":"Arthritis Rheum"},{"key":"1606_CR5","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1359\/JBMR.050601","volume":"20","author":"M Stolina","year":"2005","unstructured":"Stolina M, Adamu S, Ominsky M, Dwyer D, Asuncion F, Geng Z, Middleton S, Brown H, Pretorius J, Schett G, Bolon B, Feige U, Zack D, Kostenuik PJ (2005) RANKL is the marker and mediator of local and systemic bone loss in two rat models of inflammatory arthritis. J Bone Miner Res 20:1756\u20131765","journal-title":"J Bone Miner Res"},{"key":"1606_CR6","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/nm1538","volume":"13","author":"D Diarra","year":"2007","unstructured":"Diarra D, Stolina M, Polzer K, Zwerina J, Ominsky MS, Dwyer D, Korb A, Smolen S, Hoffmann M, Scheinecker C, van der Heide D, Landewe R, Lacey D, Richards WG, Schett G (2007) Dickkopf-1 is a master regulator of joint remodeling. Nat Med 13:156\u2013163","journal-title":"Nat Med"},{"key":"1606_CR7","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S8756-3282(99)00162-3","volume":"25","author":"LC Hofbauer","year":"1999","unstructured":"Hofbauer LC, Lacey DL, Dunstan CR, Spelsberg TC, Riggs BL, Khosla S (1999) Interleukin-1beta and tumor necrosis factor alpha, but not interleukin-6 stimulate osteoprotegerin ligand gene expression in human osteolastic cells. Bone 25:255\u2013259","journal-title":"Bone"},{"key":"1606_CR8","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.cytogfr.2004.06.004","volume":"15","author":"S Theoleyre","year":"2004","unstructured":"Theoleyre S, Wittrant Y, Tat SK, Fortun Y, Redini F, Heymann D (2004) The molecular triad OPG\/RANK\/RANKL: involvement in the orchestration of pathophysiological bone remodeling. Cytokine Growth Factor Rev 15:457\u2013475","journal-title":"Cytokine Growth Factor Rev"},{"key":"1606_CR9","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cytogfr.2003.10.005","volume":"15","author":"S Kwan Tat","year":"2004","unstructured":"Kwan Tat S, Padrines M, Theolyre S, Heymann D, Fortun Y (2004) IL-6, RANKL, TNF-alpha\/IL-1: interrelation in bone resorption pathophysiology. Cytokine Growth Factor Rev 15:49\u201360","journal-title":"Cytokine Growth Factor Rev"},{"key":"1606_CR10","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.1210\/en.140.10.4382","volume":"140","author":"LC Hofbauer","year":"1999","unstructured":"Hofbauer LC, Gori F, Riggs BL, Lacey DL, Dunstan CR, Spelsberg TC, Khosla S (1999) Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanisms of glucocorticoid-induced osteoporosis. Endocrinology 140:4382\u20134389","journal-title":"Endocrinology"},{"key":"1606_CR11","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s002239900416","volume":"62","author":"P Oelzner","year":"1998","unstructured":"Oelzner P, M\u00fcller A, Deschner F, H\u00fcller M, Abendroth K, Hein G, Stein G (1998) Relationship between disease activity and serum levels of vitamin D metabolites and PTH in rheumatoid arthritis. Calcif Tissue Int 62:193\u2013198","journal-title":"Calcif Tissue Int"},{"key":"1606_CR12","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s007740170046","volume":"19","author":"T Sugiyama","year":"2001","unstructured":"Sugiyama T (2001) Involvement of interleukin-6 and prostaglandin E2 in periarticular osteoporosis of postmenopausal women with rheumatoid arthritis. J Bone Miner Res 19:89\u201396","journal-title":"J Bone Miner Res"},{"key":"1606_CR13","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1210\/jc.86.5.2032","volume":"86","author":"C Scheidt-Nave","year":"2001","unstructured":"Scheidt-Nave C, Bismar H, Leidig-Bruckner G, Woitge H, Seibel M, Ziegler R, Pfeilschifter J (2001) Serum interleukin 6 is a major predictor of bone loss in women specific to the first decade past menopause. J Endocrinol Metab 86:2032\u20132042","journal-title":"J Endocrinol Metab"},{"key":"1606_CR14","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0531-5565(00)00220-5","volume":"36","author":"N Giuliani","year":"2001","unstructured":"Giuliani N, Sansoni P, Girasole G, Vescovini R, Passeri G, Passeri M, Pedrazzoni M (2001) Serum interleukin-6, soluble interleukin-6 receptor and soluble gp130 exhibit different patterns of age- and menopause-related changes. Exp Gerontol 36:547\u2013557","journal-title":"Exp Gerontol"},{"key":"1606_CR15","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1189\/jlb.1105674","volume":"80","author":"S Rose-John","year":"2006","unstructured":"Rose-John S, Scheller J, Elson G, Jones SA (2006) Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: role in inflammation and cancer. J Leukoc Biol 80:227\u2013236","journal-title":"J Leukoc Biol"},{"key":"1606_CR16","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00430-006-0019-9","volume":"195","author":"J Scheller","year":"2006","unstructured":"Scheller J, Rose-John S (2006) Interleukin-6 and its receptor: from bench to bedside. Med Microbiol Immunol 195:173\u2013183","journal-title":"Med Microbiol Immunol"},{"key":"1606_CR17","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1002\/art.21818","volume":"54","author":"PJ Richards","year":"2006","unstructured":"Richards PJ, Nowell MA, Horiuchi S, McLoughlin RM, Fielding CA, Grau S, Yamamoto N, Ehrmann M, Rose-John S, Williams AS, Jones SA (2006) Functional characterization of a soluble gp130 isofrom and its therapeutic capacity in an experimental model of inflammatory arthritis. Arthritis Rheum 54:1662\u20131672","journal-title":"Arthritis Rheum"},{"key":"1606_CR18","doi-asserted-by":"crossref","first-page":"613","DOI":"10.4049\/jimmunol.182.1.613","volume":"182","author":"MA Nowell","year":"2009","unstructured":"Nowell MA, Williams AS, Carty SA, Scheller J, Hayes AJ, Jones GW, Richards PJ, Slinn S, Ernst M, Jenkins BJ, Topley N, Rose-John S, Jones SA (2009) Therapeutic targeting of IL-6 trans-signaling counteracts STAT3 control of experimental inflammatory arthritis. J Immunol 182:613\u2013622","journal-title":"J Immunol"},{"key":"1606_CR19","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA (1988) The American Rheumatism Association 1987 revised criteria for classification of rheumatoid arthritis. Arthritis Rheum 31:315\u2013324","journal-title":"Arthritis Rheum"},{"key":"1606_CR20","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00393-007-0151-y","volume":"66","author":"U Lange","year":"2007","unstructured":"Lange U, M\u00fcller-Ladner U (2007) Glucocorticoid-induced osteoporosis. Z Rheumatol 66:129\u2013136","journal-title":"Z Rheumatol"},{"key":"1606_CR21","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/BF01419951","volume":"16","author":"A M\u00fcller","year":"1996","unstructured":"M\u00fcller A, Hein G, Franke S, Herrmann D, Henzgen S, Roth A, Stein G (1996) Quantitative analysis of pyridinium crosslinks of collagen in the synovial fluid of patients with rheumatoid arthritis using high-performance liquid chromatography. Rheumatol Int 16:23\u201328","journal-title":"Rheumatol Int"},{"key":"1606_CR22","volume-title":"An introductory guide to SPSS for windows","year":"2005","unstructured":"Einspruch EL (ed) (2005) An introductory guide to SPSS for windows. Sage, Thousand Oaks, London, New Delhi"},{"key":"1606_CR23","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1210\/jc.2007-2325","volume":"93","author":"C Ding","year":"2008","unstructured":"Ding C, Parameswaran V, Udayan R, Burgess J, Jones G (2008) Circulating levels of inflammatory markers predict change in bone mineral density and resorption in older adults: a longitudinal study. J Clin Endocrinol Metab 93:1952\u20131958","journal-title":"J Clin Endocrinol Metab"},{"key":"1606_CR24","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1210\/jc.2002-020092","volume":"88","author":"SL Ferrrari","year":"2003","unstructured":"Ferrrari SL, Ahn-Luong L, Garnero P, Humphries SE, Greenspan SL (2003) Two promotor polymorphisms regulating interleukin-6 gene expression are associated with circulating levels of c-reactive protein and markers of bone resorption in postmenopausal women. J Endocrinol Metab 88:255\u2013259","journal-title":"J Endocrinol Metab"},{"key":"1606_CR25","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.bone.2008.04.006","volume":"43","author":"SK Tat","year":"2008","unstructured":"Tat SK, Pelletier JP, Lajeuinesse D, Fahmi H, Duval N, Martel-Pelletier J (2008) Differential modulation of RANKL isoforms by human osteoarthritic subchondral bone osteoblasts: influence of osteotropic factors. Bone 43:284\u2013291","journal-title":"Bone"},{"key":"1606_CR26","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1006\/bbrc.2000.3379","volume":"275","author":"T Nakashima","year":"2000","unstructured":"Nakashima T, Kobayashi Y, Yamasaki S, Kawakami A, Eguchi K, Sasaki H, Sakai H (2000) Protein expression and functional difference of membrane-bound and soluble receptor activator of NFkappaB ligand: modulation of the expression by osteotropic factors and cytokines. Biochem Biophys Res Commun 275:768\u2013775","journal-title":"Biochem Biophys Res Commun"},{"key":"1606_CR27","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.4049\/jimmunol.169.6.3353","volume":"169","author":"P Palmqvist","year":"2002","unstructured":"Palmqvist P, Persson E, Conaway HH, Lerner UH (2002) IL-6, leukaemia inhibitory factor, and oncostatin M stimulate bone resorption and regulate the expression of receptor activator of NF-kappa B ligand, osteoprotegerin, and receptor activator of NF-kappa B in mouse calvariae. J Immunol 169:3353\u20133362","journal-title":"J Immunol"},{"key":"1606_CR28","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1172\/JCI19872","volume":"113","author":"NA Sims","year":"2004","unstructured":"Sims NA, Jenkins BJ, Quinn JM, Nakamura A, Glatt M, Gillespie MT, Ernst M, Martin TJ (2004) Glycoprotein 130 regulates bone turnover and bone size by distinct downstream signaling pathways. J Clin Invest 113:379\u2013389","journal-title":"J Clin Invest"},{"key":"1606_CR29","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.mce.2008.08.025","volume":"310","author":"NA Sims","year":"2009","unstructured":"Sims NA (2009) Gp130 signaling in bone cell biology: multiple roles revealed by analysis of genetically altered mice. Mol Cell Endocrinol 310:30\u201339","journal-title":"Mol Cell Endocrinol"},{"key":"1606_CR30","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1002\/j.1460-2075.1994.tb06368.x","volume":"13","author":"V Poli","year":"1994","unstructured":"Poli V, Balena R, Fattori E, Markatos A, Yamamoto M, Tanaka H, Ciliberto G, Roadan GA, Costantini F (1994) Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion. EMBO J 13:1189\u20131196","journal-title":"EMBO J"},{"key":"1606_CR31","doi-asserted-by":"crossref","first-page":"14728","DOI":"10.1073\/pnas.232562799","volume":"99","author":"M Hayashi","year":"2002","unstructured":"Hayashi M, Rho MC, Enomoto A, Fukami A, Kim YP, Kikuchi Y, Sunazaka T, Hirose T, Komiyama K, Omura S (2002) Suppression of bone resorption by madindoline A, a novel nonpeptide antagonist to gp130. Proc Natl Acad Sci USA 99:14728\u201314733","journal-title":"Proc Natl Acad Sci USA"},{"key":"1606_CR32","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1210\/en.2003-0839","volume":"145","author":"HI Shin","year":"2004","unstructured":"Shin HI, Divieti P, Sims NA, Kobayashi T, Miao D, Karapalis A, Baron R, Bringhurst R, Kronenberg HM (2004) Gp130-mediated signalling is necessary for normal osteoblastic function in vivo and in vitro. Endocrinology 145:1376\u20131385","journal-title":"Endocrinology"},{"key":"1606_CR33","doi-asserted-by":"crossref","first-page":"4683","DOI":"10.1210\/en.140.10.4683","volume":"140","author":"A Grey","year":"1999","unstructured":"Grey A, Mitnick MA, Masiukiewicz U, Sun BH, Rudikoff S, Jilka RL, Manolagas SC, Insogna K (1999) A role of interleukin-6 in parathyroid hormone-induced bone resorption in vivo. Endocrinology 140:4683\u20134690","journal-title":"Endocrinology"},{"key":"1606_CR34","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/art.21537","volume":"54","author":"PK Wong","year":"2006","unstructured":"Wong PK, Quinn JM, Sims NA, van Nieuwenhuijze A, Campbell IK, Wicks IP (2006) Interleukin-6 modulates production of T-lymphocyte-derived cytokines in antigen-induced arthritis and drives inflammation-induced osteoclastogenesis. Arthritis Rheum 54:158\u2013168","journal-title":"Arthritis Rheum"},{"key":"1606_CR35","doi-asserted-by":"crossref","first-page":"16879","DOI":"10.1074\/jbc.M200546200","volume":"277","author":"C Vermes","year":"2002","unstructured":"Vermes C, Jacobs JJ, Zhang J, Firneisz G, Roebuck KA, Glant TT (2002) Shedding of the interleukin-6 (IL-6) receptor (gp80) determines the ability of IL-6 to induce gp130 phosphorylation in human osteoblasts. J Biol Chem 277:16879\u201316887","journal-title":"J Biol Chem"},{"key":"1606_CR36","doi-asserted-by":"crossref","first-page":"11924","DOI":"10.1073\/pnas.90.24.11924","volume":"90","author":"T Tamura","year":"1993","unstructured":"Tamura T, Udagawa N, Takahashi N, Miyaura C, Tanaka S, Yamada Y, Koishihara Y, Ohsugi Y, Kumaki K, Taga T et al (1993) Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6. Proc Natl Acad Sci USA 90:11924\u201311928","journal-title":"Proc Natl Acad Sci USA"},{"key":"1606_CR37","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/jbmr.5650110113","volume":"11","author":"S Kotake","year":"1996","unstructured":"Kotake S, Sato K, Kim KJ, Takahashi N, Udagawa N, Nakamura I, Yamaguchi A, Kishimoto T, Suda T, Kashiwazaki S (1996) Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation. J Bone Miner Res 11:88\u201395","journal-title":"J Bone Miner Res"},{"key":"1606_CR38","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1210\/en.2004-1167","volume":"146","author":"XH Liu","year":"2005","unstructured":"Liu XH, Kirschenbaum SA, Yao S, Levine AC (2005) Crosstalk between the interleukin-6 and prostaglandin E(2) signaling systems results in enhancement of osteoclastogenesis through effects on the osteoprotegerin\/receptor activator of nuclear factor-(kappa)B (RANK) ligand\/RANK system. Endocrinology 146:1991\u20131998","journal-title":"Endocrinology"},{"key":"1606_CR39","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1196\/annals.1346.047","volume":"1068","author":"XH Liu","year":"2006","unstructured":"Liu XH, Kirschenbaum A, Yao S, Levine AC (2006) Interactive effect of interleukin-6 and prostaglandin E2 on osteoclastogenesis via the OPG\/RANKL\/RANK system. Ann Acad Sci 1068:225\u2013233","journal-title":"Ann Acad Sci"},{"key":"1606_CR40","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.joca.2008.09.007","volume":"17","author":"C Sanchez","year":"2009","unstructured":"Sanchez C, Gabay O, Salvat C, Henrotin YE, Berenbaum F (2009) Mechanical loading highly increases IL-6 production and decreases OPG expression by osteoblasts. Osteoarthr Cartil 17:473\u2013481","journal-title":"Osteoarthr Cartil"},{"key":"1606_CR41","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.bone.2004.11.004","volume":"36","author":"G Mossetti","year":"2005","unstructured":"Mossetti G, Rendina D, De Filippo G, Viceconti R, Di Domenico G, Cioffi M, Postiglione L, Nunziata V (2005) Interleukin-6 and osteoprotegerin systems in Paget\u2019s disease of bone: relationship to risedronate treatment. Bone 36:540\u2013554","journal-title":"Bone"},{"key":"1606_CR42","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.bone.2004.02.006","volume":"35","author":"H Tsangari","year":"2004","unstructured":"Tsangari H, Findlay DM, Kuliwaba JS, Atkins GJ, Fazzalari NL (2004) Increased expression of IL-6 and RANK mRNA in human trabecular bone from fragility fracture of the femoral neck. Bone 35:334\u2013342","journal-title":"Bone"},{"key":"1606_CR43","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1210\/jc.2007-1645","volume":"93","author":"IA Nakchbandi","year":"2008","unstructured":"Nakchbandi IA, Lang R, Kinder B, Insogna KL (2008) The role of the receptor activator of nuclear factor-kappaB ligand\/osteoprotegerin cytokine system in primary hyperparathyroidism. J Clin Endocrinol Metab 93:967\u2013973","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 2","key":"1606_CR44","first-page":"N108","volume":"17","author":"K Insogna","year":"2002","unstructured":"Insogna K, Mitnick M, Pascarella J, Nakchbandi I, Grey A, Masiukiewicz U (2002) Role of the interleukin-6\/interleukin-6 soluble receptor cytokine system in mediating increased skeletal sensitivity to parathyroid hormone in perimenopausal women. J Bone Miner Res 17(Suppl 2):N108\u2013N116","journal-title":"J Bone Miner Res"},{"key":"1606_CR45","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1749-6632.2002.tb04207.x","volume":"966","author":"A Angeli","year":"2002","unstructured":"Angeli A, Dovio A, Sartori ML, Masera RG, Ceoloni B, Prolo P, Racca S, Chiappelli F (2002) Interactions between glucocorticoids and cytokines in the bone microenvironment. Ann NY Acad Sci 966:97\u2013107","journal-title":"Ann NY Acad Sci"},{"key":"1606_CR46","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1556\/ABiol.53.2002.3.7","volume":"53","author":"A Polgar","year":"2002","unstructured":"Polgar A, Brozik M, Toth S, Holub M, Falus A (2002) A synthetic corticosteroid, dexamethasone regulates generation of soluble form of interleukin-6 receptor of human lymphocytes, in vitro. Acta Biol Hung 53:307\u2013315","journal-title":"Acta Biol Hung"},{"key":"1606_CR47","doi-asserted-by":"crossref","first-page":"5518","DOI":"10.4049\/jimmunol.158.11.5518","volume":"158","author":"K Murakami-Mori","year":"1997","unstructured":"Murakami-Mori K, Mori S, Taga T, Kishimoto T, Nakamura S (1997) Enhancement of gp130-mediated tyrosine phosphorylation of STAT3 and its DNA-binding activity in dexamethasone-treated AIDS-associated Kaposi`s sarcoma cells: selective synergy between dexamethasone and gp130-related growth factors in Kaposi`s sarcoma cell proliferation. J Immunol 158:5518\u20135526","journal-title":"J Immunol"},{"key":"1606_CR48","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1677\/joe.0.1590323","volume":"159","author":"T Takeda","year":"1998","unstructured":"Takeda T, Kurachi H, Yamamoto T, Nishio Y, Nakatsuji Y, Morishige K-i, Miyake A, Murata Y (1998) Crosstalk between the interleukin-(IL-6)-JAK-STAT and the glucocorticoid-nuclear receptor pathway: synergistic activation of IL-6 response element by IL-6 and glucocorticoid. J Endocrinol 159:323\u2013330","journal-title":"J Endocrinol"},{"key":"1606_CR49","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1530\/eje.1.02147","volume":"154","author":"A Dovio","year":"2006","unstructured":"Dovio A, Perazzolo L, Saba L, Termine A, Capobianco M, Bertolotto A, Angeli A (2006) High dose glucocorticoids increase serum levels of soluble IL-6 receptor alpha and its ratio to soluble gp130: an additional mechanism for early increased bone resorption. Eur J Endocrinol 154:745\u2013751","journal-title":"Eur J Endocrinol"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-010-1606-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-010-1606-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-010-1606-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,3]],"date-time":"2023-06-03T05:52:02Z","timestamp":1685771522000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-010-1606-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,7]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["1606"],"URL":"https:\/\/doi.org\/10.1007\/s00296-010-1606-z","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9,7]]}}}